What the data show about allergic reactions to COVID-19 vaccines
A new report from the CDC reveals how rare severe reactions actually are and what people can do if they are worried about taking the shot.
As vaccination efforts against COVID-19 haltingly ramp up across the United States, the country’s public health officials are confirming that severe allergic reactions to the Pfizer-BioNTech COVID-19 vaccine are rare.
In a study released January 6 by the U.S. Centers for Disease Control and Prevention (CDC), researchers revealed that the risk of anaphylaxis—a severe, potentially life-threatening allergic reaction—from the vaccine is extremely low. Based on data from people who have received the first of the two recommended doses, only about one in every 90,000 people, on average, will experience this adverse reaction. That’s less than 3 percent of the lifetime risk of dying from choking on food.
Technically, the chance of severe allergic reactions from the Pfizer-BioNTech vaccine
